Stocks TelegraphStocks Telegraph
Stock Ideas

SGMO Financial Statements and Analysis

NASDAQ : SGMO

Sangamo Therapeutics, Inc.

$1.25
0.01+0.81%
Open: 10:00 AM
63.78
BESG ScoreESG Rating

SGMO FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

SGMO Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue49.412M356.00K481.00K2.042M9.398M
cost of revenue02.573M2.526M2.982M9.511M
gross profit49.412M-2.217M-2.045M-940.001K-113.00K
gross profit ratio1.00-6.228-4.252-0.46-0.012
research and development expenses27.732M24.223M34.591M51.206M57.089M
general and administrative expenses11.049M12.045M11.767M13.099M13.918M
selling and marketing expenses00-3.026M-2.882M0
selling general and administrative expenses11.049M12.045M8.741M10.217M13.918M
other expenses01.172M4.349M044.799M
operating expenses38.781M31.822M43.332M61.423M71.007M
cost and expenses38.781M37.44M45.858M64.405M71.007M
interest income129.00K001.491M3.515M
interest expense00000
depreciation and amortization02.573M2.526M2.982M89.598M
ebitda10.631M-33.481M-44.871M-59.381M-16.81M
ebitda ratio0.215-94.048-89.087-29.08-1.789
operating income10.631M-37.084M-45.377M-62.363M-106.408M
operating income ratio0.215-104.169-94.339-30.54-11.322
total other income expenses net129.00K1.03M-3.614M1.795M-44.799M
income before tax10.76M-36.054M-48.991M-60.568M-102.893M
income before tax ratio0.218-101.275-101.852-29.661-10.948
income tax expense88.00K74.00K98.00K-272.00K1.27M
net income10.672M-36.128M-49.089M-60.296M-104.163M
net income ratio0.216-101.483-102.056-29.528-11.084
eps0.045-0.18-0.27-0.34-0.59
eps diluted0.044-0.18-0.27-0.34-0.59
weighted average shs out208.345M203.946M180.342M177.619M176.547M
weighted average shs out dil214.325M203.946M180.342M177.619M177.171M
Graph

SGMO Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents
short term investments
cash and short term investments
net receivables
inventory
other current assets
total current assets
property plant equipment net
goodwill
intangible assets
goodwill and intangible assets
long term investments
tax assets
other non current assets
total non current assets
other assets
total assets
account payables
short term debt
tax payables
deferred revenue
other current liabilities
total current liabilities
long term debt
deferred revenue non current
deferred tax liabilities non current
other non current liabilities
total non current liabilities
other liabilities
capital lease obligations
total liabilities
preferred stock
common stock
retained earnings
accumulated other comprehensive income loss
other total stockholders equity
total stockholders equity
total equity
total liabilities and stockholders equity
minority interest
total investments
total debt
net debt
Graph

SGMO Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax00-140.00K182.00K50.685M
stock based compensation3.065M2.719M6.107M6.189M6.79M
change in working capital2.537M-8.895M783.00K-2.673M-3.33M
accounts receivables126.00K586.00K425.00K1.568M4.31M
inventory0002.119M1.196M
accounts payables285.00K-4.939M10.809M-2.119M-1.196M
other working capital2.126M-4.542M-10.451M-4.241M-7.64M
other non cash items8.869M16.20M26.00K45.752M-6.532M
net cash provided by operating activities-26.884M-48.663M-50.538M-47.293M-60.711M
investments in property plant and equipment00-2.671M-2.744M-5.54M
acquisitions net000-40.371M-48.008M
purchases of investments000-7.439M-15.887M
sales maturities of investments035.84M40.379M47.81M63.895M
other investing activites127.00K35.84M040.371M48.008M
net cash used for investing activites127.00K35.84M37.708M37.627M42.468M
debt repayment00000
common stock issued-454.00K22.524M216.00K720.00K5.994M
common stock repurchased146.00K-402.00K0-101.00K719.00K
dividends paid00000
other financing activites-79.00K-402.00K-49.00K-719.00K-194.00K
net cash used provided by financing activities-533.00K22.122M167.00K-100.00K6.519M
effect of forex changes on cash-257.00K-670.00K1.353M-550.00K313.00K
net change in cash-27.547M10.129M-11.31M-10.316M-11.411M
cash at end of period27.786M55.333M45.204M58.014M68.33M
cash at beginning of period55.333M45.204M56.514M68.33M79.741M
operating cashflow-26.884M-48.663M-50.538M-47.293M-60.711M
capital expenditure00-2.671M-2.744M-5.54M
free cash flow-26.884M-48.663M-53.209M-50.037M-66.251M
Graph

Frequently Asked Questions

How did Sangamo Therapeutics, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, SGMO generated $49.41M in revenue last quarter, while its costs came in at $0.00.

Last quarter, how much Gross Profit did Sangamo Therapeutics, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Sangamo Therapeutics, Inc. reported a $49.41M Gross Profit for the quarter ended Jun 30, 2024.

Have SGMO's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. SGMO incurred $38.78M worth of Operating Expenses, while it generated $10.63M worth of Operating Income.

How much Net Income has SGMO posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Sangamo Therapeutics, Inc., the company generated $10.67M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Sangamo Therapeutics, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Sangamo Therapeutics, Inc. as of the end of the last quarter was -.

What are SGMO's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, SGMO had Total Net Receivables of -.

In terms of Total Assets and Current Assets, where did Sangamo Therapeutics, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of SGMO were -, while the Total Assets stand at -.

As of the last quarter, how much Total Debt did Sangamo Therapeutics, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of SGMO's debt was - at the end of the last quarter.

What were SGMO's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, SGMO reported total liabilities of -.

How much did SGMO's Working Capital change over the last quarter?

Working Capital Change for SGMO was $2.54M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

SGMO generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. SGMO generated -$26.88M of Cash from Operating Activities during its recently reported quarter.

What was SGMO's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. SGMO reported a -$27.55M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph